Trump Plans 100% Duty on Patented Drugs in New Round of Tariffs
President Donald Trump has announced a new round of tariffs, including a 100% duty on branded or patented pharmaceutical products starting October 1. This move is aimed at encouraging pharmaceutical companies to establish manufacturing plants in the United States. The tariff will be waived for companies that are actively building manufacturing facilities in America. This decision is part of the Trump administration's ongoing efforts to address the high cost of prescription drugs and to promote domestic manufacturing. The new tariffs are expected to have a significant impact on the pharmaceutical industry and could potentially lead to changes in the way drugs are priced and distributed in the United States.
Source: For the complete article, please visit the original source link below.
